Getinge reports Q3 2026 financial results
The company achieved increased profitability and strong cash flow. Acute Care Therapies drove sales growth while Surgical Workflows reported stable order intake.
See the latest news and media coverage for Getinge. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical technology and life sciences solutions company
getinge.comLast updated
In short: Getinge reported strong 2026 results, announced executive departures, and secured FDA approvals.
The company achieved increased profitability and strong cash flow. Acute Care Therapies drove sales growth while Surgical Workflows reported stable order intake.
The report releases on October 21, 2026, at 8:00 a.m. CEST, followed by a conference call with CEO Mattias Perjos and CFO Agneta Palmér.
Sales grew 4.6% organically, adjusted EBITA margin 17.6%, and free cash flow improved.
The combined entity accelerates innovation in transplant care, launching new products and entering new markets.
Swedish medical equipment maker Getinge reported third-quarter core earnings above market expectations on Wednesday, helped by a favourable product mix and disciplined pricing.
AQR Capital Management has taken a public position equivalent to 0.50% of the capital.
Swedish medtech company Getinge announced today that the president of its Life Science business is resigning to pursue an external opportunity.
AQR Capital becomes new public short seller in Getinge AQR Capital Management is also the only public short seller in the company. However, a total of 3.37 percent of the capital...
Track Getinge and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Getinge and other trending companies.